Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04671342 · ClinicalTrials.gov registry record · NA
DreamKit Diagnostic Validation
A NA study, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT04671342: Completed NA study, sponsored by Philips Clinical & Medical Affairs Global.
NCT04671342 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 306 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04671342, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
This study has been developed in order to demonstrate diagnostic efficacy of the DreamKit device against polysomnography.
Primary Outcome
The primary endpoint is the intraclass correlation coefficient (ICC) for absolute agreement between the polysomnography (PSG) apnea-hypopnea index (AHI) and the DreamKit-AHI. The higher ICC indicates higher correlation/agreement between the PSG AHI and DreamKit AHI. The possible range of ICC values is 0 to 1.0. Number was the best option for the measure type because it was a correlation coefficient.
Interventions
- DEVICE DreamKit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2021-01-14 |
| Est. Completion | 2021-12-18 |
| Phase | NA |
What the finished NCT04671342 record still lists
NCT04671342 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which DreamKit is the first listed.
NCT04671342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04671342 about?
NCT04671342 is a clinical study titled "DreamKit Diagnostic Validation". This study has been developed in order to demonstrate diagnostic efficacy of the DreamKit device against polysomnography.
What is the current status of trial NCT04671342?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2021-01-14. Estimated completion is 2021-12-18.
What interventions are being tested in trial NCT04671342?
The interventions under investigation include: DreamKit (DEVICE).
Who is sponsoring clinical trial NCT04671342?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04671342's enrollment target sits among peer trials
306 324th of 2000 higher than 1,674 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI